Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


U.S. Dollar Slides Toward Biggest Annual Loss Since 2017 as 2026 Risks Loom
Oil Prices Slip Slightly as Markets Weigh Geopolitical Risks and Supply Glut Concerns
USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand
Asian Stock Markets Start New Year Higher as Tech and AI Shares Drive Gains
U.S. Stock Futures Slip as Year-End Trading Turns Cautious
South Korea Factory Output Misses Forecasts in November Amid Ongoing Economic Uncertainty
Asia Manufacturing PMI Rebounds as Exports and Tech Demand Drive Growth into 2026
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation
U.S. Dollar Steadies Ahead of Fed Minutes as Markets Eye Policy Divisions
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery
Asian Markets Slip as Precious Metals Cool, Geopolitical Tensions Weigh on Sentiment
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 



